e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
57.78
+0.63 (+1.10%)
Official Closing Price
Updated: 7:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
BSX Q3 2025 Earnings Transcript
↗
April 22, 2026
BSX Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
World Trade
BSX Q1 2026 Earnings Transcript
↗
April 22, 2026
BSX Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Economy
World Trade
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
April 22, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
Boston Scientific Corp (NYSE:BSX) Reports Mixed Q1 2026 Results, Slight Revenue Miss Amid Profit Beat
↗
April 22, 2026
Via
Chartmill
Boston Scientific Corp (NYSE:BSX) Presents a Compelling Growth and Technical Setup Case
↗
April 18, 2026
Via
Chartmill
Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales
April 22, 2026
Medical device company Boston Scientific (NYSE:BSX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 11.6% year on year to...
Via
StockStory
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
April 21, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Boston Scientific Stock Is Trending Today: What To Know Now
↗
April 21, 2026
Boston Scientific Corp. (NYSE:BSX) shares are in the spotlight on Tuesday after Stifel maintained a Buy rating and lowered its price target on the stock.
Via
Benzinga
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
April 21, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Boston Scientific (BSX) Q1 Earnings: What To Expect
April 20, 2026
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. Boston Scien...
Via
StockStory
Topics
Artificial Intelligence
Robbins LLP Encourages BSX Stockholders to Contact the Firm for Information About the Class Action Against Boston Scientific
April 20, 2026
From
Robbins LLP
Via
Business Wire
Top S&P500 movers in Monday's session
↗
April 20, 2026
Via
Chartmill
What's going on in today's session: S&P500 movers
↗
April 20, 2026
Via
Chartmill
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
April 18, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
1 Cash-Producing Stock for Long-Term Investors and 2 That Underwhelm
April 17, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
BSX INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation
April 16, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance
April 15, 2026
As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9...
Via
MarketMinute
Topics
Economy
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
April 15, 2026
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...
Via
MarketMinute
Topics
Economy
Wall Street’s Renaissance: Bank of America Shatters Q1 2026 Estimates as M&A and Trading Volatility Surge
April 15, 2026
The financial landscape of 2026 has been marked by a return to high-stakes deal-making and intense market fluctuations, and no institution seems more equipped to navigate this era than Bank of America...
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
April 14, 2026
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of...
Via
MarketMinute
Topics
Bankruptcy
Earnings
Economy
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
April 14, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Avanos Medical to be Acquired by American Industrial Partners for $1.27 Billion; Stock Surges 69%
April 14, 2026
The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American...
Via
MarketMinute
Topics
Economy
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
April 14, 2026
NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across...
Via
MarketMinute
Topics
Economy
Intellectual Property
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
April 14, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge
April 09, 2026
The global financial landscape underwent a seismic shift in the first quarter of 2026, as a "perfect storm" of stabilizing interest rates and technological urgency triggered a historic wave of mergers...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
April 09, 2026
Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories...
Via
Finterra
Topics
Economy
World Trade
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
April 09, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
April 07, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
April 07, 2026
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a...
Via
Finterra
Topics
Artificial Intelligence
Retirement
World Trade
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
April 07, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.